March 21, 2013 |
A compounding company in Augusta, Ga., has recalled syringes of the cancer drug Avastin it supplied over five months to physicians treating vision problems after the Food and Drug Administration received word that five patients who received the compounded medication came down with eye infections that could leave them blind. The FDA announced the recall Thursday after regulators conducted a preliminary inspection of Clinical Specialties Compounding Pharmacy and found "practices at the site that raise concerns about a lack of sterility assurance.
February 14, 2013 |
The FDA on Thursday approved a bionic eye that improves vision for patients blinded by a rare eye condition called retinitis pigmentosa. The Argus II system , a video camera and transmitter mounted on eyeglasses, translates light and movement into electrical signals, which are sent directly to an array of electrodes implanted into a patient's retina. Clinical trials have demonstrated that for patients whose retinal cells have been ravaged by the genetic condition, the visual prosthetic device helps restore the ability to perform many daily activities.
May 7, 2012
It sounds too good to be true, but a Chicago doctor is reporting that a drug-like dietary supplement, or nutriceutical, called Longevinex -- which contains the purported anti-aging chemical resveratrol -- may control or even reverse the symptoms of wet macular degeneration, a severe form of visual impairment. If the results prove to hold up, the treatment would have a great advantage over existing ones, which require injection of chemicals directly into the eye. Longevinex, in contrast, can be taken orally.
February 20, 2012 |
British actress Judi Dench is seeking to downplay fears over the revelation that she is suffering from a degenerative eye condition. The Oscar-winning Dench, perhaps best known as James Bond's mysterious boss M, has been dealing with two different forms of macular generation -- one in each eye. According to Reuters, she can no longer read scripts and has to have someone read them out loud to her, "like reading me a story. " According to the National Eye Institute, macular degeneration occurs in an area known as the macula, which sits at the center of the light-sensitive tissue known as the retina, located at the back of the eye socket.
January 23, 2012 |
Two patients with vision problems who received injections of retinal cells made from human embryonic stem cells have seen marked improvement in their vision four months later, according to a preliminary study on the safety and efficacy of the pioneering treatment. The report , published online Monday in the journal Lancet, is the first to describe results of an actual treatment derived from human embryonic stem cells. The patients -- one with dry age-related macular degeneration and the other with a pediatric version of the disease called Stargardt's macular dystrophy -- were treated at UCLA over the summer.
April 28, 2011 |
The cancer drug Avastin may work just as effectively as the more expensive Lucentis at treating age-related macular degeneration, new research suggests. But the potential side effects bear watching. The early results of a clinical trial comparing the two drugs was published online Thursday in the New England Journal of Medicine , slightly ahead of schedule. Avastin doesn’t have FDA approval to treat AMD -- it’s approved to prevent the growth of blood vessels that fuel tumors.